2 completed, 1 recruiting, 1 unknown. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 1 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Technophage, SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury Eletriptan HBr 40 mg - Acute Spinal Cord Injury (SCI) | Phase 1 / Phase 2 | Recruiting | Technophage, SA | 28 | 2025-08-01 | 2025-09-09 |
| Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia TP-122A - Pneumonia, Ventilator-Associated | Phase 1 / Phase 2 | Unknown | Technophage, SA | 15 | 2024-09-01 | 2024-04-17 |
| Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection TP-102, Placebo - Diabetic Foot Infection | Phase 2 | Completed | Technophage, SA | 76 | 2023-11-08 | 2025-12-22 |
| Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers TP-102 - Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection | Phase 1 / Phase 2 | Completed | Technophage, SA | 20 | 2021-03-22 | 2022-10-04 |
Acinetobacter Infections (1) · Diabetic Foot (1) · Pneumonia, Ventilator-Associated (1) · Pseudomonas Infections (1) · Staphylococcal Infections (1)
eletriptan (1)
France (1) · India (1) · Israel (1) · Spain (1) · United States (1)
Abdul Moosa, PI (1) · Aman Khanna (1) · Margarida Barreto, Msc (1) · Mohammad Qureshi (1) · Parikh Niranjan (1) · Ran Nir-Paz, MD (1) · Ronen Ben Ami, MD (1) · Sachin Arsule (1) · Sanjay Kala (1) · Senthil Kumar (1) · Stan Mathis, PI (1) · Vikas Matai (1) · Yalamanchi Rao (1)
2023 (1)